NCT04037436 2025-04-13
MoveStrong
University of Waterloo
Phase NA Completed
Clinical Trials
17 trialsNCT02742597 2023-03-17
PACEinMM-ON
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Phase NA Completed
NCT00058188 2020-12-08
Zolendronate for the Prevention of Bone Loss in Men w/ Prostate CA on Long-Term Androgen Deprivation
Northwestern University
Phase 3 Terminated
NCT00303784 2020-11-27
PATCH
University College, London
Phase 3 Unknown
NCT00329797 2017-11-29
Zoledronate in Preventing Osteoporosis and Bone Fractures in Patients With Locally Advanced Nonmetastatic Prostate Cancer Undergoing Radiation Therapy and Hormone Therapy
Radiation Therapy Oncology Group
Phase 3 Completed
NCT00925600 2017-05-30
Evaluation of New or Worsening Lens Opacifications in Men With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss
Amgen
Phase 3 Completed
NCT00172055 2017-03-06
Study to Assess Efficacy and Safety of Zoledronic Acid and the Value of Markers of Bone Resorption in the Prediction of Bone Metastases and Cancer Treatment-induced Bone Loss (CTIBL) in Patients With Prostate Cancer on Hormone Therapy
Novartis
Phase 3 Completed
NCT00043069 2016-12-07
Calcium With or Without Estrogen and/or Risedronate in Preventing Osteoporosis in Patients With Prostate Cancer
Alliance for Clinical Trials in Oncology
Phase 3 Completed
NCT01694784 2016-04-19
Understanding and Discouraging Overuse of Potentially Harmful Screening Tests
University of North Carolina, Chapel Hill
Phase NA Completed
NCT00660686 2015-10-21
Exercise for Physical Health in Men With Prostate Cancer
OHSU Knight Cancer Institute
Phase NA Completed
NCT00129142 2013-11-15
Toremifene Citrate for Prevention of Bone Fractures in Men With Prostate Cancer on Androgen Deprivation Therapy
GTx
Phase 3 Completed
NCT00003903 2013-10-16
Effect of Androgen Suppression on Bone Loss in Patients With or Without Bone Metastases Secondary to Prostate Cancer
University of Rochester
Phase NA Completed
NCT00957606 2011-04-13
Osteoporosis
Odense University Hospital
Phase 3 Unknown
NCT00048841 2010-03-02
Prevention of Osteoporosis in Men With Prostate Cancer
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Phase 3 Completed
NCT00551044 2007-10-30
Bicalutamide Monotherapy Has Significant Quality of Life Benefits for Men With Advanced Prostate Cancer
Wirral University Teaching Hospital NHS Trust
Phase NA Completed
NCT00536653 2007-09-28
Changes in Bone Mineral Density and Fracture Risk in Patients Receiving Androgen Deprivation Therapy for Prostate Cancer
Wirral University Teaching Hospital NHS Trust
Phase NA Completed
NCT00520052 2007-08-23
Frequency of Zoledronic Acid to Prevent Further Bone Loss in Osteoporotic Patients Requiring Androgen Deprivation Therapy for Prostate Cancer
Wirral University Teaching Hospital NHS Trust
Phase NA Completed